Evidence map›Paper›PMID 32548300›Full record

ArticleTomography (Ann Arbor, Mich.)2020

Radiomics Prediction of EGFR Status in Lung Cancer-Our Experience in Using Multiple Feature Extractors and The Cancer Imaging Archive Data.

Lin Lu, Shawn H Sun, Hao Yang, Linning E, Pingzhen Guo, Lawrence H Schwartz, Binsheng Zhao

Open access · goldAbstract read
In one paragraph

Article in Tomography (Ann Arbor, Mich.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 4 pooled it
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 4 syntheses or guidelines pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Comparison of three freeware software packages forJapanese journal of radiology · 2021
    Article
  16. Observational
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Lin LuDepartment of Radiology, New York Presbyterian Hospital, Columbia University Medical Center, New York, NY; and.
Shawn H SunDepartment of Radiology, New York Presbyterian Hospital, Columbia University Medical Center, New York, NY; and.
Hao YangDepartment of Radiology, New York Presbyterian Hospital, Columbia University Medical Center, New York, NY; and.
Linning EDepartment of Radiology, Shanxi DAYI Hospital, Taiyuan, Shanxi, China.
Pingzhen GuoDepartment of Radiology, New York Presbyterian Hospital, Columbia University Medical Center, New York, NY; and.
Lawrence H SchwartzDepartment of Radiology, New York Presbyterian Hospital, Columbia University Medical Center, New York, NY; and.
Binsheng ZhaoDepartment of Radiology, New York Presbyterian Hospital, Columbia University Medical Center, New York, NY; and.
NewYork–Presbyterian Hospital · USColumbia University Irving Medical Center · USNew York Hospital Queens · USShanxi Dayi Hospital · CN

Funding

Integrating Radiomics into S0819 and Lung-MAP, Biomarker Driven Clinical Trials for Lung CancerU01CA225431 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI SCHWARTZ, LAWRENCE H, ZHAO, BINSHENG · 2018 to 2022
$3.1M
NCI NIH HHS U01 CA225431
6 · The paper itself

Abstract

We investigated the performance of multiple radiomics feature extractors/software on predicting epidermal growth factor receptor mutation status in 228 patients with non-small cell lung cancer from publicly available data sets in The Cancer Imaging Archive. The imaging and clinical data were split into training (n = 105) and validation cohorts (n = 123). Two of the most cited open-source feature extractors, IBEX (1563 features) and Pyradiomics (1319 features), and our in-house software, Columbia Image Feature Extractor (CIFE) (1160 features), were used to extract radiomics features. Univariate and multivariate analyses were performed sequentially to predict EGFR mutation status using each individual feature extractor. Our univariate analysis integrated an unsupervised clustering method to identify nonredundant and informative candidate features for the creation of prediction models by multivariate analyses. In training, unsupervised clustering-based univariate analysis identified 5, 6, and 4 features from IBEX, Pyradiomics, and CIFE as candidate features, respectively. Multivariate prediction models using these features from IBEX, Pyradiomics, and CIFE yielded similar areas under the receiver operating characteristic curve of 0.68, 0.67, and 0.69. However, in validation, areas under the receiver operating characteristic curve of multivariate prediction models from IBEX, Pyradiomics, and CIFE decreased to 0.54, 0.56 and 0.64, respectively. Different feature extractors select different radiomics features, which leads to prediction models with varying performance. However, correlation between those selected features from different extractors may indicate these features measure similar imaging phenotypes associated with similar biological characteristics. Overall, attention should be paid to the generalizability of individual radiomics features and radiomics prediction models.

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsAgedErbB ReceptorsFemaleHumansMaleROC CurveSoftwareEGFR protein, humanErbB ReceptorsEGFRIBEXNSCLCPyradiomicsRadiomicsTCIA

Identifiers

PMID32548300
PMCPMC7289249
OpenAlexW3033186726

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.